Business · 19/10/2012Updated: 10/17/2026 · 1 min read
FDA's Nonprescription Drugs Advisory Committee to Review and Amend Notice Regarding Over-the-Counter Medications
Summary
The US Food and Drug Administration's Nonprescription Drugs Advisory Committee will review and potentially amend a notice related to over-the-counter medications, following a request from the public to update the guidelines.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →